DealBook: Amgen Said to Be Near Deal to Buy Onyx for $10.5 Billion
Sunday, August 25, 2013 - 11:10
in Mathematics & Economics
The biotech giant Amgen is near a deal to buy Onyx Pharmaceuticals, a maker of cancer-fighting drugs, for about $125 a share, people briefed on the matter said on Saturday.